MANN MICHAEL SCOTT (President) purchased 0.0% of their position (8K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $309.30 — a small addition. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 11/7/2018ACC: 0001645627-18-000070
Officer10% Owner· President
Since Jun 2018
+8K
Net shares
Net buyer
$309.30
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
8K acquired
Non-Derivative Transactions6
Common Stock
Direct
Shares
+1K
Price / share
$0.04
Trade value
$39.60
% of position
0.0%
11/2/2018
26.12M→26.13M
Common Stock
Direct
Shares
+1K
Price / share
$0.04
Trade value
$41.40
% of position
0.0%
11/2/2018
26.13M→26.13M
Common Stock
Direct
Shares
+1K
Price / share
$0.04
Trade value
$37.90
% of position
0.0%
11/5/2018
26.13M→26.13M
Common Stock
Direct
Shares
+2K
Price / share
$0.04
Trade value
$75.20
% of position
0.0%
11/5/2018
26.13M→26.13M
Common Stock
Direct
Shares
+1K
Price / share
$0.04
Trade value
$38.20
% of position
0.0%
11/5/2018
26.13M→26.13M
Common Stock
Direct
Shares
+2K
Price / share
$0.04
Trade value
$77.00
% of position
0.0%
11/6/2018
26.13M→26.13M
Total
Net shares
+8K
Net value
$309.30
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/2/2018 | P · Purchase | +1K | $0.04 | $39.60 | 0.0% | 26.12M | 26.13M |
| Common Stock Direct | 11/2/2018 | P · Purchase | +1K | $0.04 | $41.40 | 0.0% | 26.13M | 26.13M |
| Common Stock Direct | 11/5/2018 | P · Purchase | +1K | $0.04 | $37.90 | 0.0% | 26.13M | 26.13M |
| Common Stock Direct | 11/5/2018 | P · Purchase | +2K | $0.04 | $75.20 | 0.0% | 26.13M | 26.13M |
| Common Stock Direct | 11/5/2018 | P · Purchase | +1K | $0.04 | $38.20 | 0.0% | 26.13M | 26.13M |
| Common Stock Direct | 11/6/2018 | P · Purchase | +2K | $0.04 | $77.00 | 0.0% | 26.13M | 26.13M |
| Total | +8K | $309.30 | ||||||
Derivative Transactions0
No derivative transactions reported